Recon: Merck seeks US authorization for COVID drug; EMA reviewing Regeneron, Roche COVID antibody

Recon

ReconMichael Mezher

Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy